Intravascular ultrasound results from the NEVO ResElution-I trial: a randomized, blinded comparison of sirolimus-eluting NEVO stents with paclitaxel-eluting TAXUS Liberté stents in de novo native coronary artery lesions.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples